Lipoproteoplex Hybrid Encapsulates Drugs and Binds to siRNA (IMAGE)

NYU Tandon School of Engineering

Lipoproteoplex Hybrid Encapsulates Drugs and Binds to siRNA

Caption

A new hybrid compound called a lipoproteoplex, developed in the lab at the NYU Tandon School of Engineering, uses a lipid "container" for transfection -- the transportation of material past a cell membrane -- and an easy-to-make protein capsule that can bind both small chemotherapeutic molecules and genetic technology, such as short interfering RNA (siRNA), that can "silence" genes that propagate disease states.

Credit

NYU Tandon

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.